Hikma Pharmaceutical reported 255M in Operating Profit for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Artemis Alpha ATS:LN -10207000 58.81M
AstraZeneca AZN:LN 878M 1.17B
Bayer BAYN:GR 4.21B 2.19B
Fresenius FRE:GR € 902M 221M
Fresenius Medical Care FMS:US $ 347.67M 101.49M
Galapagos GLPG:NA -21146000 31.3M
Genmab GEN:DC 514M 295M
GlaxoSmithKline GSK:LN 2.8B 1.91B
GRIFOLS GRF:SM € 250.6M 37.64M
H. Lundbeck A/S LUN:DC 875M 869M
Hikma Pharmaceutical HIK:LN 255M 88M
Lonza Group LONN:SW 534M 217M
Merck MRK:GR € 1173M 134M
Orion ORNBV:FH 71.5M 31.6M
Recordati REC:IM 131.27M 14.01M